EGFR and neoplasm: miR-198 was also able to inhibit growth of tumor grafts in nude mouse. FGFR1, a lung cancer oncogene, which is a membrane-bound receptor tyrosine kinase that regulates proliferation via the MAPK and PI3K pathway, much like EGFR, was found to be a direct target of miR-198 [69].